Woodline Partners’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.96M | Buy |
465,152
+344
| +0.1% | +$5.15K | 0.04% | 503 |
|
|
2025
Q1 | $7.5M | Buy |
464,808
+112,128
| +32% | +$1.81M | 0.05% | 412 |
|
|
2024
Q4 | $8.21M | Buy |
352,680
+88,424
| +33% | +$2.06M | 0.06% | 388 |
|
|
2024
Q3 | $7.77M | Buy |
264,256
+1,640
| +0.6% | +$48.2K | 0.07% | 333 |
|
|
2024
Q2 | $6.17M | Buy |
262,616
+162,089
| +161% | +$3.81M | 0.06% | 315 |
|
|
2024
Q1 | $3.81M | Buy |
+100,527
| New | +$3.81M | 0.04% | 387 |
|